• Lymphoma & blood cancers
  • Acute Leukaemia
Name No. Patient Profile Purpose
Protocol 04-30 15-36

Myelodysplastic Syndrome after failure of drugs called Hypomethylating Agents

The purpose of this trial is to evaluate whether adding the drug rigosertib to the patient’s doctor’s choice (standard of care treatment) works better and is as safe as the doctor’s choice.